BR1100534A - Carbamatos substituìdos de 1-(piridilamino substituìdo) -1h-indol-5-ila - Google Patents

Carbamatos substituìdos de 1-(piridilamino substituìdo) -1h-indol-5-ila

Info

Publication number
BR1100534A
BR1100534A BR1100534-3A BR1100534A BR1100534A BR 1100534 A BR1100534 A BR 1100534A BR 1100534 A BR1100534 A BR 1100534A BR 1100534 A BR1100534 A BR 1100534A
Authority
BR
Brazil
Prior art keywords
loweralkyl
hydrogen
substituted
arylloweralkyl
indol
Prior art date
Application number
BR1100534-3A
Other languages
English (en)
Inventor
Richard C Effland
Larry Davis
Gordon E Olsen
Joseph T Klein
David G Wettlaufer
Peter A Nemoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR1100534A publication Critical patent/BR1100534A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR1100534-3A 1990-07-23 1997-04-13 Carbamatos substituìdos de 1-(piridilamino substituìdo) -1h-indol-5-ila BR1100534A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/555,890 US5102891A (en) 1990-07-23 1990-07-23 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates

Publications (1)

Publication Number Publication Date
BR1100534A true BR1100534A (pt) 2000-03-14

Family

ID=24218998

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100534-3A BR1100534A (pt) 1990-07-23 1997-04-13 Carbamatos substituìdos de 1-(piridilamino substituìdo) -1h-indol-5-ila

Country Status (23)

Country Link
US (1) US5102891A (pt)
EP (1) EP0468401B1 (pt)
JP (1) JP2564714B2 (pt)
KR (1) KR100201515B1 (pt)
AT (1) ATE171176T1 (pt)
AU (1) AU639581B2 (pt)
BR (1) BR1100534A (pt)
CA (1) CA2047531C (pt)
CZ (1) CZ283253B6 (pt)
DE (1) DE69130196T2 (pt)
DK (1) DK0468401T3 (pt)
ES (1) ES2121761T3 (pt)
FI (1) FI102067B (pt)
HU (1) HUT58317A (pt)
IE (1) IE912567A1 (pt)
IL (1) IL98920A (pt)
MX (1) MX9100342A (pt)
NO (1) NO300132B1 (pt)
NZ (1) NZ239038A (pt)
PL (1) PL291185A1 (pt)
PT (1) PT98413B (pt)
SG (1) SG48059A1 (pt)
ZA (1) ZA915723B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
CZ284437B6 (cs) * 1991-04-17 1998-11-11 Hoechst Marion Roussel, Inc. Substituované (pyridinylamino)-benzisoxazoly a -benzo[b]thiofeny, způsob jejich přípravy farmaceutický prostředek obsahující tyto sloučeniny a použití těchto sloučenin
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
US6004977A (en) * 1996-12-27 1999-12-21 Hoechst Marion Roussel, Inc. N-(pyridinylamino) isoindolines and related compounds
HUP0000783A2 (hu) * 1996-12-27 2001-04-28 Hoechst Marion Roussel, Inc. N-(piridinil-amino)-izoindolinok és származékaik, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2888238B1 (fr) * 2005-07-07 2007-09-07 Servier Lab Nouveaux derives 1h-indole-pyridinecarboxamides et 1h-indole-piperidinecarboxamide, leur procede de preparation et les compositions pharceumatiques qui les contiennent.
CN109662964A (zh) * 2010-02-09 2019-04-23 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
CN112843005B (zh) 2015-05-22 2023-02-21 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
ATE115143T1 (de) * 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US4992448A (en) * 1989-10-24 1991-02-12 Hoechst-Roussel Pharmaceuticals Inc. Benzocycloalkylaminopyridinamines and related compounds as topical antiinflammatory agents for the treatment of skin disorders

Also Published As

Publication number Publication date
CA2047531A1 (en) 1992-01-24
JPH04243878A (ja) 1992-08-31
ZA915723B (en) 1992-04-29
PL291185A1 (en) 1993-04-05
NO912866D0 (no) 1991-07-22
EP0468401A3 (en) 1992-07-29
SG48059A1 (en) 1998-04-17
CS228191A3 (en) 1992-02-19
FI913502A (fi) 1992-01-24
ES2121761T3 (es) 1998-12-16
JP2564714B2 (ja) 1996-12-18
DE69130196D1 (de) 1998-10-22
NO300132B1 (no) 1997-04-14
FI913502A0 (fi) 1991-07-19
US5102891A (en) 1992-04-07
FI102067B1 (fi) 1998-10-15
NO912866L (no) 1992-01-24
HUT58317A (en) 1992-02-28
MX9100342A (es) 1992-02-28
IL98920A (en) 1995-08-31
KR100201515B1 (ko) 1999-06-15
ATE171176T1 (de) 1998-10-15
NZ239038A (en) 1994-04-27
HU912450D0 (en) 1991-12-30
AU8121691A (en) 1992-01-30
DE69130196T2 (de) 1999-04-01
IE912567A1 (en) 1992-01-29
CA2047531C (en) 2003-01-07
KR920002585A (ko) 1992-02-28
EP0468401A2 (en) 1992-01-29
AU639581B2 (en) 1993-07-29
DK0468401T3 (da) 1999-06-14
CZ283253B6 (cs) 1998-02-18
PT98413B (pt) 1999-01-29
FI102067B (fi) 1998-10-15
EP0468401B1 (en) 1998-09-16
PT98413A (pt) 1992-05-29

Similar Documents

Publication Publication Date Title
BR1100534A (pt) Carbamatos substituìdos de 1-(piridilamino substituìdo) -1h-indol-5-ila
ES2079530T3 (es) 1-(piridinilalquil)-1h-indoles, -indolinas y compuestos analogos relacionados.
DK0471298T3 (da) Carbamoyl-1-(pyridinylalkyl)-1H-indoler, -indoliner og belægtede forbindelser

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96
TC Change of name
TE Change of address